Miller Anestesia

1240 / 2894

282. Parikh CR, Mishra J, Thiessen-Philbrook H, et al:
Urinary IL-18 is an early predictive biomarker of
acute kidney injury after cardiac surgery. Kidney Int
70:199–203, 2006.
283. Levin A: Cystatin C, serum creatinine, and estima-
tes of kidney function: Searching for better measu-
res of kidney function and cardiovascular risk. Ann
Intern Med 142:586–588, 2005.
284. Grubb A, Bjork J, Lindstrom V, et al: A cystatin
C–based formula without anthropometric varia-
bles estimates glomerular filtration rate better than
creatinine clearance using the Cockcroft-Gault
formula. Scand J Clin Lab Invest 65:153–162,
2005.
285. Momeni M, Baele P, Jacquet L, et al: Cystatin C in
cardiac surgery. Acta Anaesthesiol Belg 58:107–112,
2007.
286. Zhu J, Yin R, Wu H, et al: Cystatin C as a reliable
marker of renal function following heart valve
replacement surgery with cardiopulmonary bypass.
Clin Chim Acta 374:116–121, 2006.
287. Abu-Omar Y, Mussa S, Naik MJ, et al: Evaluation of
cystatin C as a marker of renal injury following
on-pump and off-pump coronary surgery. Eur J
Cardiothorac Surg 27:893–898, 2005.
288. Smith GL, Lichtman JH, Bracken MB, et al: Renal
impairment and outcomes in heart failure: systema-
tic review and meta-analysis. J Am Coll Cardiol
47:1987–1996, 2006.
289. Jernberg T, Lindahl B, James S, et al: Cystatin C: A
novel predictor of outcome in suspected or confir-
med non–ST-elevation acute coronary syndrome.
Circulation 110:2342–2348, 2004.
290. Traynor J, Mactier R, Geddes CC, Fox JG: How to
measure renal function in clinical practice. BMJ
333:733–737, 2006.
291. Mazul-Sunko B, Zarkovic N,Vrkic N, et al: Proatrial
natriuretic peptide(1-98), but not cystatin C, is pre-
dictive for occurrence of acute renal insufficiency in
critically ill septic patients. Nephron Clin Pract
97:c103–c107, 2004.
292. Takahira R, Yonemura K, Yonekawa O, et al:
Tryptophan glycoconjugate as a novel marker of
renal function. Am J Med 110:192–197, 2001.
293. Westhuyzen J, Endre ZH, Reece G, et al: Measure-
ment of tubular enzymuria facilitates early detec-
tion of acute renal impairment in the intensive
care unit. Nephrol Dial Trasplant 18:543–551,
2003.
294. Price RG: Urinary enzymes, nephrotoxicity and
renal disease. Toxicology 23:99–134, 1982.
295. Mueller PW, MacNeil ML, Steinberg KK: N-Acetyl-
beta-d-glucosaminidase assay in urine: Urea inhibi-
tion. J Anal Toxicol 13:188–190, 1989.
296. Stolarek I, Howey JE, Fraser CG: Biological varia-
tion of urinary N -acetyl-beta-d-glucosaminidase:
Practical and clinical implications. Clin Chem
35:560–563, 1989.
297. Yuen CT, Price RG, Chattagoon L, et al: Colorime-
tric assays for N-acetyl-beta-d-glucosaminidase and
beta-d-galactosidase in human urine using newly-
developed omega-nitrostyryl substrates. Clin Chim
Acta 124:195–204, 1982.
298. Hofmann W, Guder WG: A diagnostic programme
for quantitative analysis of proteinuria. J Clin Chem
Clin Biochem 27:589–600, 1989.
299. Robinson D, Stirling JL: N-Acetyl-beta-glucosami-
nidases in human spleen. Biochem J 107:321–327,
1968.
300. Price RG, Dance N, Richards B, Cattell WR: The
excretion of N-acetyl-beta-glucosaminidase and
beta-galactosidase following surgery to the kidney.
Clin Chim Acta 27:65–72, 1970.
301. Tucker SM, Pierce RJ, Price RG: Characterisation of
human N -acetyl-beta-d-glucosaminidase isoenzy-
mes as an indicator of tissue damage in disease. Clin
Chim Acta 102:29–40, 1980.
302. Whiting PH, Petersen J, Power DA, et al: Diagnostic
value of urinary N-acetyl-beta-d-glucosaminidase,
its isoenzymes and the fractional excretion of
sodium following renal trasplantation. Clin Chim
Acta 130:369–376, 1983.
303. Eti S, Cheng CY, Marshall A, Reidenberg MM:
Urinary clusterin in chronic nephrotoxicity
in the rat. Proc Soc Exp Biol Med 202:487–490,
1993.
304. Girardi AC, Degray BC, Nagy T, et al: Association
of Na-H exchanger isoform NHE3 and dipeptidyl
peptidase IV in the renal proximal tubule. J Biol
Chem 276:46671–46677, 2001.
305. du Cheyron D, Daubin C, Poggioli J, et al: Urinary
measurement of Na/H exchanger isoform 3 (NHE3)
protein as new marker of tubule injury in critically
ill patients with ARF. Am J Kidney Dis 42:497–506,
2003.
306. Stafford-Smith M: Antifibrinolytic agents make
alpha1- and beta2-microglobulinuria poor markers
of post cardiac surgery renal dysfunction. Anesthe-
siology 90:928–929, 1999.
307. Mogensen CE, Solling K: Studies on renal tubular
protein reabsorption: Partial and near complete
inhibition by certain amino acids. Scand J Clin Lab
Invest 37:477–486, 1977.
308. Rustom R, Maltby P, Grime JS, et al: Effects of lysine
infusion on the renal metabolism of aprotinin
(Trasylol) in man. Clin Sci (Colch) 83:295–299,
1992.
309. Feindt PR, Walcher S, Volkmer I, et al: Effects of
high-dose aprotinin on renal function in aortocoro-
nary bypass grafting. Ann Thorac Surg 60:1076–
1080, 1995.
310. Karlsson FA, Wibell L, Evrin PE: Beta 2-microglo-
bulin in clinical medicine. Scand J Clin Lab Invest
Suppl 154:27–37, 1980.
311. NordenAG,Flynn FV: Degradation of beta 2-micro-
globulin in infected urine by leukocyte elastase-like
activity. Clin Chim Acta 134:167–176, 1983.
312. Dehne MG, Boldt J, Heise D, et al: Tamm-Horsfall
protein, alpha-1- and beta-2-microglobulin as
kidney function markers in heart surgery. Anaes-
thesist 44:545–551, 1995.
313. Gormley SM, McBride WT, Armstrong MA, et al:
Plasma and urinary cytokine homeostasis and renal
dysfunction during cardiac surgery. Anesthesiology
93:1210–1216, 2000.
314. Harrison JF, Parker RW, De Silva KL: Lysozymuria
and acute disorders of renal function. J Clin Pathol
26:278–284, 1973.
315. Mishra J, Mori K, Ma Q, et al: Amelioration of ische-
mic acute renal injury by neutrophil gelatinase-
associatedlipocalin.JAmSocNephrol15:3073–3082,
2004.
316. Mishra J, Ma Q, Prada A, et al: Identification of
neutrophil gelatinase-associated lipocalin as a novel
early urinary biomarker for ischemic renal injury.
J Am Soc Nephrol 14:2534–2543, 2003.
317. Wagener G, Jan M, Kim M, et al: Association
between increases in urinary neutrophil gelatinase-
associated lipocalin and acute renal dysfunction
after adult cardiac surgery.Anesthesiology 105:485–
491, 2006.
318. Parikh CR, Abraham E, Ancukiewicz M, Edelstein
CL: Urine IL-18 is an early diagnostic marker for
acute kidney injury and predicts mortality in the
intensive care unit. J Am Soc Nephrol 16:3046–
3052, 2005.
319. Parikh CR, Jani A, Melnikov VY, et al: Urinary
interleukin-18 is a marker of human acute tubular
necrosis. Am J Kidney Dis 43:405–414, 2004.
320. Mariano F, Guida G, Donati D, et al: Production of
platelet-activating factor in patients with sepsis-
associated acute renal failure. Nephrol Dial Tras-
plant 14:1150–1157, 1999.
321. Ichimura T, Bonventre JV, Bailly V, et al: Kidney
injury molecule-1 (KIM-1), a putative epithelial cell
adhesion molecule containing a novel immunoglo-
bulin domain, is up-regulated in renal cells after
injury. J Biol Chem 273:4135–4142, 1998.
322. Ichimura T, Hung CC, Yang SA, et al: Kidney injury
molecule-1: A tissue and urinary biomarker for
nephrotoxicant-induced renal injury. Am J Physiol
Renal Physiol 286:F552–F563, 2004.
323. Han WK, Bailly V, Abichandani R, et al: Kidney
Injury Molecule-1 (KIM-1): A novel biomarker for
human renal proximal tubule injury. Kidney Int
62:237–244, 2002.
324. Muramatsu Y, Tsujie M, Kohda Y, et al: Early detec-
tion of cysteine rich protein 61 (CYR61, CCN1) in
urine following renal ischemic reperfusion injury.
Kidney Int 62:1601–1610, 2002.
325. Davidman M, Olson P, Kohen J, et al: Iatrogenic
renal disease. Arch Intern Med 151:1809–1812,
1991.
326. McCullough PA, Wolyn R, Rocher LL, et al: Acute
renal failure after coronary intervention: Incidence,
risk factors, and relationship to mortality.Am J Med
103:368–375, 1997.
327. Diehl JT, Cali RF, Hertzer NR, Beven EG: Compli-
cations of abdominal aortic reconstruction: An
analysis of perioperative risk factors in 557 patients.
Ann Surg 197:49–56, 1983.
328. Crawford ES, Crawford JL, Safi HJ, et al: Thoracoab-
dominal aortic aneurysms: Preoperative and intrao-
perative factors determining immediate and
long-term results of operations in 605 patients.
J Vasc Surg 3:389–404, 1986.
329. Luke RG: Can renal failure due to hypertension be
prevented? Hypertension 18:I139–I142, 1991.
330. Kurella M, Lo JC, Chertow GM: Metabolic syn-
drome and the risk for chronic kidney disease
among nondiabetic adults. J Am Soc Nephrol
16:2134–2140, 2005.
331. Aronson S, Boisvert D, Lapp W: Isolated systolic
hypertension is associated with adverse outcomes
from coronary artery bypass grafting surgery.
Anesth Analg 94:1079–1084, 2002.
332. Hou SH, Bushinsky DA, Wish JB, et al: Hospital-
acquired renal insufficiency: A prospective study.
Am J Med 74:243–248, 1983.
333. Wilson RF, Soullier G, Antonenko D: Creatinine
clearance in critically ill surgical patients.Arch Surg
114:461–467, 1979.
334. McCreath BJ, Swaminathan M, Booth JV, et al:
Mitral valve surgery and acute renal injury: Port
access versus median sternotomy. Ann Thorac Surg
75:812–819, 2003.
335. Fischer SS, Phillips-Bute B, Swaminathan M, et al:
Symmetry aortic connector devices and acute renal
injury: A comparison of renal dysfunction after
three different aortocoronary bypass surgery tech-
niques. Anesth Analg 102:25–31, 2006.
336. Stafford-Smith M, Swaminathan M, McCreath BJ, et
al: Morbidity-related serum creatinine patterns after
coronary bypass surgery. Anesth Analg 92:SCA123,
2001.
337. Swaminathan M, Knauth K, Phillips-Bute B, et al:
Acute renal dysfunction after cardiac trasplant
surgery: A comparison with other forms of cardiac
surgery. Anesth Analg 94:SCA102, 2002.
338. Morozowich S, Lin S, Phillips-Bute B, et al: Aproti-
nin use and allograft function after off-pump bila-
teral lung trasplantation. Anesth Analg 102:SCA6,
2006.
339. Ten Clay S, Phillips-Bute B, Glower D, et al:
Aortic valve replacement and acute kidney injury:
Minimally invasive parasternotomy versus
median sternotomy. Anesth Analg 106:SCA124,
2008.
340. Stafford-Smith M, Patel U, Phillips-Bute B, et al:
Acute kidney injury and chronic kidney disease
after cardiac surgery. Adv Chronic Kidney Dis
15:157–177, 2008.
341. Hix JK, Thakar CV, Katz EM, et al: Effect of off-
pump coronary artery bypass graft surgery on
postoperative acute kidney injury and mortality.
Crit Care Med 34:2979–2983, 2006.
342. Mehta RH, Grab JD, O’Brien SM, et al: Bedside tool
for predicting the risk of postoperative dialysis in
patients undergoing cardiac surgery. Circulation
114:2208–2216, 2006, quiz 2208,.
343. Appoo JJ, Augoustides JG, Pochettino A, et al:
Perioperative outcome in adults undergoing elective
deep hypothermic circulatory arrest with retrograde
cerebral perfusion in proximal aortic arch repair:
Evaluation of protocol-based care. J Cardiothorac
Vasc Anesth 20:3–7, 2006.
1240 Control de la anestesia III